Evidence map›Paper›PMID 28258221›Full record

ArticleThe Journal of biological chemistry2017

Quantitative mapping of microtubule-associated protein 2c (MAP2c) phosphorylation and regulatory protein 14-3-3ζ-binding sites reveals key differences between MAP2c and its homolog Tau.

Séverine Jansen, Kateřina Melková, Zuzana Trošanová, Kateřina Hanáková, Milan Zachrdla, Jiří Nováček, Erik Župa, Zbyněk Zdráhal, Jozef Hritz, Lukáš Žídek

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Séverine JansenFrom the National Centre for Biomolecular Research, Faculty of Science, and.
Kateřina MelkováFrom the National Centre for Biomolecular Research, Faculty of Science, and.
Zuzana TrošanováFrom the National Centre for Biomolecular Research, Faculty of Science, and.
Kateřina Hanákováthe Central European Institute of Technology, Masaryk University, Kamenice 5, CZ-62500 Brno, Czech Republic.
Milan ZachrdlaFrom the National Centre for Biomolecular Research, Faculty of Science, and.
Jiří Nováčekthe Central European Institute of Technology, Masaryk University, Kamenice 5, CZ-62500 Brno, Czech Republic.
Erik ŽupaFrom the National Centre for Biomolecular Research, Faculty of Science, and.
Zbyněk Zdráhalthe Central European Institute of Technology, Masaryk University, Kamenice 5, CZ-62500 Brno, Czech Republic.
Jozef HritzFrom the National Centre for Biomolecular Research, Faculty of Science, and jozef.hritz@ceitec.muni.cz.
Lukáš ŽídekFrom the National Centre for Biomolecular Research, Faculty of Science, and lzidek@chemi.muni.cz.
Central European Institute of Technology – Masaryk University · CZMasaryk University · CZCentral European Institute of Technology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microtubule-associated protein 2c (MAP2c) is involved in neuronal development and is less characterized than its homolog Tau, which has various roles in neurodegeneration. Using NMR methods providing single-residue resolution and quantitative comparison, we investigated molecular interactions important for the regulatory roles of MAP2c in microtubule dynamics. We found that MAP2c and Tau significantly differ in the position and kinetics of sites that are phosphorylated by cAMP-dependent protein kinase (PKA), even in highly homologous regions. We determined the binding sites of unphosphorylated and phosphorylated MAP2c responsible for interactions with the regulatory protein 14-3-3ζ. Differences in phosphorylation and in charge distribution between MAP2c and Tau suggested that both MAP2c and Tau respond to the same signal (phosphorylation by PKA) but have different downstream effects, indicating a signaling branch point for controlling microtubule stability. Although the interactions of phosphorylated Tau with 14-3-3ζ are supposed to be a major factor in microtubule destabilization, the binding of 14-3-3ζ to MAP2c enhanced by PKA-mediated phosphorylation is likely to influence microtubule-MAP2c binding much less, in agreement with the results of our tubulin co-sedimentation measurements. The specific location of the major MAP2c phosphorylation site in a region homologous to the muscarinic receptor-binding site of Tau suggests that MAP2c also may regulate processes other than microtubule dynamics.

Indexed as

14-3-3 ProteinsAmino Acid MotifsAnimalsBinding SitesCyclic AMP-Dependent Protein KinasesKineticsMagnetic Resonance SpectroscopyMass SpectrometryMicrotubule-Associated ProteinsMicrotubulesNeuronsPhosphorylationProtein BindingRatsSignal Transductiontau Proteins14-3-3 ProteinsCyclic AMP-Dependent Protein KinasesMAP2 protein, ratMapt protein, ratMicrotubule-Associated Proteinstau ProteinsTubulin14-3-3 proteinmass spectrometry (MS)microtubule-associated protein (MAP)nuclear magnetic resonance (NMR)protein kinase A (PKA)

Identifiers

PMID28258221
PMCPMC5399119
OpenAlexW2593320865

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.